Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
Hoekstra CJ, Stroobants SG, Smit EF, Vansteenkiste J, van Tinteren H, Postmus PE, Golding RP, Biesma B, Schramel FJ, van Zandwijk N, Lammertsma AA, Hoekstra OS. Hoekstra CJ, et al. Among authors: van tinteren h, van zandwijk n. J Clin Oncol. 2005 Nov 20;23(33):8362-70. doi: 10.1200/JCO.2005.01.1189. J Clin Oncol. 2005. PMID: 16293866 Clinical Trial.
Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.
Smit EF, Burgers SA, Biesma B, Smit HJ, Eppinga P, Dingemans AM, Joerger M, Schellens JH, Vincent A, van Zandwijk N, Groen HJ. Smit EF, et al. Among authors: van zandwijk n. J Clin Oncol. 2009 Apr 20;27(12):2038-45. doi: 10.1200/JCO.2008.19.1650. Epub 2009 Mar 23. J Clin Oncol. 2009. PMID: 19307503 Clinical Trial.
Preliminary results of two dose-finding studies of paclitaxel (Taxol) and carboplatin in non-small cell lung and ovarian cancers: a European Cancer Centre effort.
Giaccone G, Huizing M, ten Bokkel Huinink W, Koolen M, Postmus P, van Kralingen K, van Zandwijk N, Vermorken J, Beijnen J, Dalesio O, et al. Giaccone G, et al. Among authors: van kralingen k, van zandwijk n. Semin Oncol. 1994 Oct;21(5 Suppl 8):34-8. Semin Oncol. 1994. PMID: 7939761 Clinical Trial.
Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Splinter TA, Sahmoud T, Festen J, van Zandwijk N, Sörenson S, Clerico M, Burghouts J, Dautzenberg B, Kho GS, Kirkpatrick A, Giaccone G. Splinter TA, et al. Among authors: van zandwijk n. J Clin Oncol. 1996 Jan;14(1):127-34. doi: 10.1200/JCO.1996.14.1.127. J Clin Oncol. 1996. PMID: 8558187 Clinical Trial.
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.
Huizing MT, Giaccone G, van Warmerdam LJ, Rosing H, Bakker PJ, Vermorken JB, Postmus PE, van Zandwijk N, Koolen MG, ten Bokkel Huinink WW, van der Vijgh WJ, Bierhorst FJ, Lai A, Dalesio O, Pinedo HM, Veenhof CH, Beijnen JH. Huizing MT, et al. Among authors: van der vijgh wj, van warmerdam lj, van zandwijk n. J Clin Oncol. 1997 Jan;15(1):317-29. doi: 10.1200/JCO.1997.15.1.317. J Clin Oncol. 1997. PMID: 8996159 Clinical Trial.
277 results